DTL
ALNY icon

Dynamic Technology Lab’s Alnylam Pharmaceuticals ALNY Stock Holding History

Dynamic Technology Lab’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,042
Closed -$222K – 951
2020
Q1 		$222K Buy
+2,042
New +$236K 0.04% 716
2019
Q4 		– Sell
-2,800
Closed -$225K – 939
2019
Q3 		$225K Buy
+2,800
New +$222K 0.04% 769
2018
Q4 		– Sell
-3,724
Closed -$326K – 953
2018
Q3 		$326K Buy
3,724
+1,324
+55% +$133K 0.05% 703
2018
Q2 		$237K Buy
+2,400
New +$238K 0.04% 786
2016
Q2 		– Sell
-5,300
Closed -$333K – 846
2016
Q1 		$333K Buy
+5,300
New +$352K 0.09% 472

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Dynamic Technology Lab's ALNY Position: Q2 2020 in Review

Dynamic Technology Lab sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2020, closing a stake of 2,042 shares — an estimated $222K sold.

Dynamic Technology Lab first reported a position in ALNY in Q1 2016 and held it in 5 quarters. The position peaked at $333K in Q1 2016. 375 funds tracked by Wall St. Rank hold ALNY as of Q2 2020.

  • Dynamic Technology Lab reported no remaining Alnylam Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Dynamic Technology Lab sold 2,042 Alnylam Pharmaceuticals shares in Q2 2020, an estimated $222K.
  • Dynamic Technology Lab first reported a position in Alnylam Pharmaceuticals in Q1 2016 and held it in 5 quarters.
  • Dynamic Technology Lab's Alnylam Pharmaceuticals position peaked at $333K in Q1 2016.
  • 375 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2020.

Based on Dynamic Technology Lab's 13F filing for Q2 2020, filed 14 Aug 2020.